KSE - Delayed Quote KRW

Boryung Corporation (003850.KS)

10,930.00 -20.00 (-0.18%)
At close: 3:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
859,625,585.76
859,625,585.76
760,475,844.69
627,279,390.05
561,866,592.45
Cost of Revenue
506,195,732.26
506,195,732.26
453,288,659.44
362,342,032.98
330,424,994.81
Gross Profit
353,429,853.50
353,429,853.50
307,187,185.25
264,937,357.07
231,441,597.64
Operating Expense
285,162,833.00
285,162,833.00
250,584,308.00
223,489,128.00
191,455,287.00
Operating Income
68,267,020.50
68,267,020.50
56,602,877.25
41,448,229.07
39,986,310.64
Net Non Operating Interest Income Expense
-8,677,377.13
-8,677,377.13
-1,603,235.28
-3,079,519.53
-2,860,928.18
Pretax Income
56,305,541.46
56,305,541.46
58,871,965.83
70,718,152.10
36,044,189.29
Tax Provision
16,092,403.20
16,092,403.20
16,933,656.40
27,598,891.72
9,184,427.37
Net Income Common Stockholders
40,202,797.52
40,202,797.52
41,894,431.74
43,044,274.38
26,856,199.16
Basic EPS
610.00
--
636.00
689.00
377.51
Diluted EPS
610.00
--
634.00
683.00
376.69
Basic Average Shares
65,906.23
--
65,871.75
62,473.55
71,140.33
Diluted Average Shares
65,906.23
--
66,079.55
63,022.36
71,294.65
Total Operating Income as Reported
68,267,020.61
68,267,020.61
56,602,877.31
41,448,228.31
39,986,310.80
Rent Expense Supplemental
3,036,796.00
3,036,796.00
2,939,456.00
2,924,488.00
--
Total Expenses
791,358,565.26
791,358,565.26
703,872,967.44
585,831,160.98
521,880,281.81
Net Income from Continuing & Discontinued Operation
40,202,797.52
40,202,797.52
41,894,431.74
43,044,274.38
26,856,199.16
Normalized Income
39,539,803.84
39,539,803.84
45,272,158.05
39,546,287.85
27,013,689.06
Interest Income
871,770.00
871,770.00
4,524,211.00
1,398,531.00
482,139.00
Interest Expense
9,549,147.00
9,549,147.00
6,127,446.00
4,478,051.00
3,343,067.00
Net Interest Income
-8,677,377.13
-8,677,377.13
-1,603,235.28
-3,079,519.53
-2,860,928.18
EBIT
65,854,688.46
65,854,688.46
64,999,411.83
75,196,203.10
39,387,256.29
EBITDA
110,241,757.46
110,241,757.46
102,643,601.83
107,270,391.10
66,953,676.29
Reconciled Cost of Revenue
506,195,732.26
506,195,732.26
453,288,659.44
362,342,032.98
330,424,994.81
Reconciled Depreciation
44,387,069.00
44,387,069.00
37,644,190.00
32,074,188.00
27,566,420.00
Net Income from Continuing Operation Net Minority Interest
40,202,797.52
40,202,797.52
41,894,431.74
43,044,274.38
26,856,199.16
Total Unusual Items Excluding Goodwill
928,309.00
928,309.00
-4,741,569.00
5,736,906.00
-211,342.00
Total Unusual Items
928,309.00
928,309.00
-4,741,569.00
5,736,906.00
-211,342.00
Normalized EBITDA
109,313,448.46
109,313,448.46
107,385,170.83
101,533,485.10
67,165,018.29
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
265,315.32
265,315.32
-1,363,842.69
2,238,919.47
-53,852.10
12/31/2020 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

003220.KS Daewon Pharmaceutical Co., Ltd.
14,930.00
-1.13%
 
000220.KS Yuyu Pharma, Inc.
4,635.00
-1.28%
 
000230.KS Ildong Holdings Co., Ltd.
8,700.00
+0.12%
 
000020.KS Dongwha Pharm.Co.,Ltd
8,700.00
-0.46%
 
019170.KS Shinpoong Pharmaceutical Co.,Ltd
13,640.00
+2.10%
 
000640.KS Dong-A Socio Holdings Co., Ltd.
112,300.00
-1.49%
 
006280.KS GC Biopharma Corp.
111,900.00
+0.72%
 
001360.KS SAMSUNG PHARM. Co., LTD.
1,684.00
+0.30%
 
128940.KS Hanmi Pharm. Co., Ltd.
310,500.00
+0.16%
 
000100.KS Yuhan Corporation
71,000.00
-0.70%